What is 5-Amino-1MQ?
5-amino-1MQ is identified in the original study as a small-molecule inhibitor of nicotinamide-N-methyltransferase, or NNMT. It is not made a peptide by appearing within a peptide catalogue category. The catalogue lists a 5 Amino 1MQ 50MG vial. Original NNMT-inhibitor study.
Investigators examined NNMT inhibitors in pre-adipocytes and measured intracellular 1-MNA in cultured adipocytes to assess inhibition. It is a different measurement from body weight or a clinical outcome in a person. Original NNMT-inhibitor study.
The 11-day mouse study
The research manuscript describes a randomized experiment in diet-induced-obese male mice, with nine mice in each cohort. The experiment lasted 11 days. Original NNMT-inhibitor study.
Measured endpoints included body weight, food intake, fat-pad weight, adipocyte size and plasma cholesterol. These measurements should not be collapsed into a single unqualified weight-loss claim. The experiment distinguished an overall body measure, food consumption, tissue measurements and a blood measurement within the mouse model. Original NNMT-inhibitor study.
The cellular and animal work answer connected but different questions. Intracellular 1-MNA was used to assess NNMT inhibition in cultured adipocytes; the animal experiment measured the named physiological endpoints over 11 days. Neither setting establishes human benefit or safety, and neither is an equivalence test between catalogue formats. Original NNMT-inhibitor study.
50mg vial presentation
The vial listing gives 50MG as its catalogue amount. This identifies the presentation, not the mouse experiment's material, a concentration or an amount for human use. The separate 5-Amino-1MQ 50mg Pen is another documented presentation; a similar amount does not establish equivalent contents or performance.
The research concerns a small-molecule NNMT inhibitor in cultured adipocytes and diet-induced-obese male mice. Original NNMT-inhibitor study.
